Weifapenin 50 mg/ ml Норвегия - норвежский - Statens legemiddelverk

weifapenin 50 mg/ ml

viatris as - fenoksymetylpenicillinkalium - pulver til mikstur, oppløsning - 50 mg/ ml

Xylocain 20 mg/ ml Норвегия - норвежский - Statens legemiddelverk

xylocain 20 mg/ ml

aspen pharma trading limited - lidokainhydroklorid - injeksjonsvæske, oppløsning - 20 mg/ ml

Xylocain 2 % Норвегия - норвежский - Statens legemiddelverk

xylocain 2 %

aspen pharma trading limited - lidokainhydrokloridmonohydrat - gel - 2 %

Xylocain 10 mg/ ml Норвегия - норвежский - Statens legemiddelverk

xylocain 10 mg/ ml

aspen pharma trading limited - lidokainhydroklorid - injeksjonsvæske, oppløsning - 10 mg/ ml

Xylocain Adrenalin 10 mg/ ml / 5 mikrog/ ml Норвегия - норвежский - Statens legemiddelverk

xylocain adrenalin 10 mg/ ml / 5 mikrog/ ml

aspen pharma trading limited - lidokainhydroklorid / adrenalintartrat - injeksjonsvæske, oppløsning - 10 mg/ ml / 5 mikrog/ ml

Spikevax (previously COVID-19 Vaccine Moderna) Европейский союз - норвежский - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaksiner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Lidbree 42 mg/ ml Норвегия - норвежский - Statens legemiddelverk

lidbree 42 mg/ ml

gedeon richter plc - lidokain - intrauteringel - 42 mg/ ml

Ophtesic 20 mg/ g Норвегия - норвежский - Statens legemiddelverk

ophtesic 20 mg/ g

ldd pharma - lidokainhydroklorid - Øyegel i endosebeholder - 20 mg/ g